The designated clinician should decide the policy in relation to the provision of an autologous service.
Autologous donors should be tested for the same microbiological markers as for an allogeneic living donor. Microbiological testing must include bacteriological culture where tissue does not undergo a validated terminal antimicrobial treatment. The medical history may be less relevant than for allogeneic donation of tissues. The rationale for any exceptions must be documented.
Separate storage must be used to avoid inappropriate issue. Autologous tissue must be securely segregated from allogeneic tissue at all stages from collection to issue. Autologous donations may not be transferred to the allogeneic bank.
A system must be in place to enable the hospital to recognise that the tissue is autologous. The autologous tissue must be labelled with the donor/recipient name, hospital number and date of birth.